Literature DB >> 30026886

An "accidental" discovery: Incidentally found metanephric adenofibroma in a 5-year-old male trauma patient.

Priya G Sharma1, Ashwini K Esnakula2, Dhanashree A Rajderkar1.   

Abstract

Metanephric adenofibroma is a rare pediatric renal tumor, which should be considered in cases of solid renal lesions that mimic Wilms tumor on both imaging and histology. We present a case of an incidentally found left renal lesion on a trauma computed tomography scan in a 5-year-old male patient. The patient underwent total nephrectomy, and the diagnosis of metanephric adenofibroma was made on histology. Radiologists should consider this entity in the differential for an incidentally found solitary renal mass in a pediatric patient. Prompting the pathologic diagnosis of this entity can spare patients from unnecessary chemotherapy and allow for nephron-sparing surgery.

Entities:  

Keywords:  Benign mass; Pediatric renal mass; Wilms

Year:  2018        PMID: 30026886      PMCID: PMC6050197          DOI: 10.1016/j.radcr.2018.02.026

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Metanephric neoplasms are rare renal neoplasms identified in both pediatric and adult populations. These neoplasms consist of metanephric adenoma, metanephric stromal tumor, and metanephric adenofibroma (MAF). MAF consists of both epithelial and stromal cells and has even been reported to merge with the morphology of Wilms tumor [1]. Less than 100 of these cases have been reported in the literature, appearing more often within pathology literature [2]. The imaging appearance of MAF is nonspecific, with the tumor often resembling the Wilms tumor. However, the management of the lesions is quite different, and correctly diagnosing MAF may spare the patient from receiving toxic chemotherapy. Therefore, MAF remains an important pathology for the radiologist to consider when reporting solid renal lesions in the pediatric population.

Case report

An otherwise healthy 5-year-old male patient, who was a restrained passenger in a high-speed motor vehicle collision, presented to the pediatric emergency room as a trauma transfer from the regional medical center for pediatric surgery evaluation. Contrast-enhanced computed tomography (CT) scan from outside the hospital (dose-length product 111.70 mGy⋅cm) reported a 3.8-cm mass arising from the anterior aspect of the left kidney, suggestive of a neoplastic process such as Wilms tumor. Review of the CT scan showed a low-attenuating lesion without calcification or necrosis. There was no invasion of the renal vein or retroperitoneal adenopathy. The kidneys showed no additional lesions to suggest nephrogenic rests. The perinephric fat planes were preserved. No metastatic lesions were identified in the abdomen or the pelvis. There were no traumatic findings otherwise (Fig. 1, Fig. 2, Fig. 3). Ultrasound was performed when the patient arrived at our institution for confirmation. Ultrasound revealed a 5.4 × 3.3 × 3.3 cm solid iso- to hypoechoic mass with mild internal vascularity emanating from the left kidney and therefore concerning for Wilms tumor (Fig. 4, Fig. 5). There was no retroperitoneal adenopathy or invasion of the renal vein. Metastatic workup with CT of the chest was negative.
Fig. 1

Axial contrast-enhanced computed tomography imaging demonstrating a homogenous solid mass with no areas of calcification or necrosis (black arrows) in the superior pole of the left kidney.

Fig. 2

Coronal contrast-enhanced computed tomography image demonstrating a solid hypodense mass (black arrow) arising from the superior pole of the left kidney.

Fig. 3

Sagittal contrast-enhanced computed tomography image demonstrating the “claw sign” (black arrows) consistent with mass (white arrow) arising from the superior pole of the left kidney.

Fig. 4

Ultrasound demonstrating a well-defined iso- to hypoechoic (to the renal cortex) solid mass (white arrows) emanating from the superior pole of the left kidney.

Fig. 5

Doppler ultrasound showing mild vascularity to the renal mass (white arrow).

Axial contrast-enhanced computed tomography imaging demonstrating a homogenous solid mass with no areas of calcification or necrosis (black arrows) in the superior pole of the left kidney. Coronal contrast-enhanced computed tomography image demonstrating a solid hypodense mass (black arrow) arising from the superior pole of the left kidney. Sagittal contrast-enhanced computed tomography image demonstrating the “claw sign” (black arrows) consistent with mass (white arrow) arising from the superior pole of the left kidney. Ultrasound demonstrating a well-defined iso- to hypoechoic (to the renal cortex) solid mass (white arrows) emanating from the superior pole of the left kidney. Doppler ultrasound showing mild vascularity to the renal mass (white arrow). After discussion of management options with the patient's parents, decision was made to undergo left nephrectomy. Because of potential for tumor upstaging, biopsy of this unilateral tumor was not recommended. Given the patient's history of trauma and “seatbelt” sign on presentation, an urgent same-day exploratory laparotomy was performed. Surgery was complicated by the presence of intraperitoneal blood and desvascularized small intestine at the distal ileum with deserosalized and perforated intestine. Small bowel resection was performed with a primary anastomosis. A complete left nephrectomy was performed with no tumor spillage. Regional periaortic lymph nodes were dissected. Intraoperative frozen section demonstrated spindle cells, and a definitive diagnosis was deferred by pathology at the time. Pathology revealed a 4.5 × 4.5 × 4.0 cm firm well-circumscribed mass limited to the right renal parenchyma (Fig. 6A). The mass had a homogenous white-to-tan cut surface without any areas of hemorrhage or necrosis. Microscopic images demonstrated a biphasic tumor with stromal and epithelial components (Fig. 6B). The stromal component was predominantly composed of spindle to stellate cells with thin tapered hyperchromatic nuclei. The stromal cellularity varied from hypocellular myxoid areas to cellular fibroblastic areas (Fig. 6C). The stromal cells were diffusely positive for CD34 by immunohistochemistry. The epithelial component was limited and was mostly identified in the subcapsular areas as unencapsulated nodules. These epithelial nodules consisted of a cellular inactive embryonal-type epithelium composed of uniform, small cuboidal cells with small hyperchromatic nuclei and scant cytoplasm forming small tubules and blunt short papillae resembling glomeruli (Fig. 6D). Overall, these histologic findings were consistent with a MAF.
Fig. 6

(A) Right kidney with a tan homogenous mass in the upper pole S (black arrow). (B) Biphasic tumor with S and E components (H&E 40×). (C) S component consistent with metanephric S tumor with hypocellular (dark black arrow) and hypercellular E (white arrow) areas composed of spindle to stellate cells. (D) E component consistent with metanephric adenoma composed of a cellular inactive embryonal-type epithelium S (black arrows) and frequent psammomatous calcifications E (white arrows). H&E, hematoxylin and eosin; E, epithelial; S, stromal.

(A) Right kidney with a tan homogenous mass in the upper pole S (black arrow). (B) Biphasic tumor with S and E components (H&E 40×). (C) S component consistent with metanephric S tumor with hypocellular (dark black arrow) and hypercellular E (white arrow) areas composed of spindle to stellate cells. (D) E component consistent with metanephric adenoma composed of a cellular inactive embryonal-type epithelium S (black arrows) and frequent psammomatous calcifications E (white arrows). H&E, hematoxylin and eosin; E, epithelial; S, stromal. After a short course of intravenous antibiotics for intermittent postoperative fevers, after remaining afebrile, the patient transitioned to oral antibiotics and was discharged home. A single follow-up retroperitoneal ultrasound 6 months later, which was negative for recurrence, confirmed a normal right kidney. Given the pathology, no further follow-up was felt necessary.

Discussion

MAF is a very rare renal tumor found in both children and adults. The tumor falls into the larger category of metanephric tumors. Histologically, metanephric tumors contain epithelial cells, stromal cells, or both and are respectively referred to as metanephric adenoma, metanephric stromal tumor, or MAF. Metanephric adenoma is the most common of the lesions and typically affects adult women [3]. Metanephric stromal tumors, on the other hand, typically present in young children with a mean age of presentation of 2 years [4]. MAF was originally termed “nephrogenic adenofibroma” and was described in 1992 by Hennigar and Beckwith [5]. Since that time, review of the literature shows that less than 30 cases have been reported in children. Although MAF is considered benign, it is difficult to distinguish from malignant lesions by imaging characteristics alone. Definitive diagnosis is typically made after surgical resection by radical or partial nephrectomy. As in our case, more than half the reported cases of MAF have been found in asymptomatic patients [2]. However, patients can present with gross hematuria when a centrally located lesion penetrates the collecting system. Clinical presentation also includes pain, hypertension, and polycythemia owing to the tumor's production of erythropoietin [1]. Solid renal tumors in the pediatric population are thought to be Wilms tumor. However, the differential for homogenous solitary solid renal lesions in the pediatric population should also include renal cell carcinoma, clear cell sarcoma, and lymphoma in the appropriate clinical setting. Aggressive features such as vascular invasion and metastatic or bilateral lesions have not been reported features of MAF, and if these imaging features are seen, alternate diagnoses should be suggested. Imaging provides no guidance in the determination of an early Wilms tumor vs the MAF. In fact, the 2 pathologies tend to share many imaging features. On CT, the lesion appears homogenously hypovascular to the renal parenchyma. Lesions can be predominantly cystic and associated with calcifications [6], [7]. Wilms tumor also tends to be hypovascular to the renal parenchyma when diagnosed early. Calcifications are seen in only 20% of Wilms tumors. Unfortunately, calcifications are also seen in pediatric renal sarcomatous lesions. Echogenicity of the MAF varies on ultrasound [8]. Case reports describe no benefit to the use of magnetic resonance imaging in the characterization of this lesion. Again, this lesion shares imaging features seen in other renal neoplasms. On T1- and T2-weighted imaging, this lesion remains hypointense. After the administration of gadolinium, this lesion demonstrates a lower signal intensity than the surrounding parenchyma [2]. Imaging features of a solitary mass without local, regional, or distant metastases should prompt the radiologist to consider MAF in an asymptomatic patient. Biopsy of unilateral renal lesions is not recommended by the Children's Oncology Group protocol as this leads to tumor upstaging [7]. Furthermore, fine-needle aspiration to effectively diagnose MAF has not been demonstrated in the literature [6]. In terms of surgical approach, if MAF is confirmed by initial biopsy or frozen section at the time of surgery, because of the tumor's benign course, nephron-sparing surgery is advocated [9]. Adjuvant chemotherapy is not necessary [10]. Rarely, MAF are associated with malignant neoplasms such as nephroblastoma or papillary renal cell carcinoma [1]. There was no histologic evidence of a nephroblastoma or a papillary renal cell carcinoma in this current case. Recent studies show that metanephric family tumors including MAF frequently show B-rapidly accelerated fibrosarcoma (BRAF) V600E mutations [4], [11], [12], which is not identified in nephroblastomas. In our case, immunohistochemistry for BRAF V600E mutation showed diffuse moderate to strong positivity in the epithelial component and patchy moderate positivity in the stromal component. Targeted next-generation sequencing confirmed the presence of BRAF V600E (c.1799T>A) mutation in the tumor. In addition, PTEN c.737C>T p.P246L was also identified. To our knowledge, PTEN mutations have not been reported in metanephric tumors. Cytogenetic studies showed normal karyotype and no clonal cytogenetic abnormalities were identified. These findings further supported the diagnosis of a MAF. MAF is an extremely rare tumor that should be considered in the differential for a non–aggressive appearing solitary pediatric renal mass presenting in an asymptomatic patient.
  12 in total

Review 1.  Nephrogenic adenofibroma. A novel kidney tumor of young people.

Authors:  R A Hennigar; J B Beckwith
Journal:  Am J Surg Pathol       Date:  1992-04       Impact factor: 6.394

2.  Frequent BRAF V600E Mutations in Metanephric Stromal Tumor.

Authors:  Pedram Argani; Justin Lee; George J Netto; Gang Zheng; Ming Tseh-Lin; Ben Ho Park
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

3.  Metanephric adenoma. Clinicopathological study of fifty patients.

Authors:  C J Davis; J H Barton; I A Sesterhenn; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1995-10       Impact factor: 6.394

4.  The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center.

Authors:  M R Arroyo; D M Green; E J Perlman; J B Beckwith; P Argani
Journal:  Am J Surg Pathol       Date:  2001-04       Impact factor: 6.394

5.  Large Cystic Metanephric Adenoma in a 15-Year-Old Girl.

Authors:  Amanda F Saltzman; Alonso Carrasco; Michael A Maccini; Brian T Caldwell; Amy L Treece; Nicholas G Cost
Journal:  Urology       Date:  2016-12-21       Impact factor: 2.649

6.  Metanephric stromal tumor: a challenging diagnostic entity in children.

Authors:  Ayper Kacar; Müjdem Nur Azili; Birsen Songül Cihan; Haci Ahmet Demir; Hüseyin Tugrul Tiryaki; Pedram Argani
Journal:  J Pediatr Surg       Date:  2011-12       Impact factor: 2.545

7.  Metanephric stromal tumor: report of 31 cases of a distinctive pediatric renal neoplasm.

Authors:  P Argani; J B Beckwith
Journal:  Am J Surg Pathol       Date:  2000-07       Impact factor: 6.394

8.  BRAF mutations in pediatric metanephric tumors.

Authors:  Rose Chami; Minzhi Yin; Paula Marrano; Chinachote Teerapakpinyo; Shanop Shuangshoti; Paul Scott Thorner
Journal:  Hum Pathol       Date:  2015-04-21       Impact factor: 3.466

9.  Metanephric adenoma of the kidney: clinical and radiological study of nine cases.

Authors:  Cyrille Bastide; Jean-Jacques Rambeaud; Ariadne M Bach; Paul Russo
Journal:  BJU Int       Date:  2009-02-11       Impact factor: 5.588

10.  Metanephric Adenofibroma Masquerading as Wilms' Tumor.

Authors:  Prince Raj; Ashwini Khanolkar; Yogesh Kumar Sarin
Journal:  APSP J Case Rep       Date:  2016-11-01
View more
  1 in total

1.  Successful management of Wilms tumor accompanied by traumatic renal injury: a case report.

Authors:  Atsuko Omori; Koichiro Yoshimaru; Ryota Souzaki; Mutsumi Nakamura; Noriyuki Kaku; Yuhki Koga; Yuichi Shibui; Akihiko Tamaki; Junkichi Takemoto; Naonori Kawakubo; Kenichi Kohashi; Shouichi Ohga; Yoshinao Oda; Toshiharu Matsuura
Journal:  Int Cancer Conf J       Date:  2021-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.